Stephen Carl Caso, PA-C

Stephen Caso practices at Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California.

Stephen Caso's NPI, 1083916985, was assigned on November 28, 2010. Stephen Caso holds California license PA21365.

Stephen Caso's primary practice is Scripps Clinic OB-GYN La Jolla Campus, at 9850 Genesee Ave, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 453-0753.

Stephen Caso's primary practice is Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California. Stephen Caso is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Perlman Clinic. Dmand AI also links Stephen Caso to 1 more hospital, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephen Caso practices, 5 sites in all. Vendor and product names are available with a free account.

Physician assistant is Stephen Caso's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Stephen Caso is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Stephen Caso is licensed in California.

Dmand AI lists acute gastroduodenitis, acute sinusitis, adjustment disease, anxiety, arthritis, asthma, bladder disease and chronic indigestion among the conditions Stephen Caso treats.

CMS data shows 4,396 Medicare services from Stephen Caso across 14 procedure codes in 2024, for 234 Medicare patients. Medicare paid $137,945 for them. Every service was in an office.

CMS counts 234 Medicare patients who saw Stephen Caso in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Stephen Caso's median patient age at 66, with 46% women.

In 2024, Stephen Caso wrote 5,966 Medicare Part D claims for 521 patients. 85% of them were for generic drugs. CMS names the drug for 5,234 of them, across 119 drugs with 11 or more claims each, at $578,372 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Stephen Caso for performance year 2024, reported as part of a group. Stephen Caso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Stephen Caso as offering telehealth.

CMS Open Payments shows 191 general payments to Stephen Caso from 39 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $580.